Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Stocks to watch next week

Published 09/16/2017, 08:00 AM
Updated 09/16/2017, 08:00 AM
© Reuters.  Stocks to watch next week
  • Notable earnings: AutoZone (NYSE:AZO), Adobe (NASDAQ:ADBE), Bed Bath & Beyond (NASDAQ:BBBY) on September 19; General Mills (NYSE:GIS) and Farmer Brothers (NASDAQ:FARM) on September 20; Presidio (NASDAQ:PSDO) and Scholastic (NASDAQ:SCHL) on September 21; Finish Line (NASDAQ:FINL) and CarMax (NYSE:KMX) on September 22.
  • IPOs expected to price: Zai Lab (Pending:ZLAB), Despegar.com (Pending:DESP), Celcuity (Pending:CELC), Krystal Biotech (Pending:KRYS) and Best (Pending:BESTI) on September 20.
  • Secondary offering lockup expirations: Financial Engines (NASDAQ:FNGN), Ring Energy (NYSEMKT:REI), WageWorks (NYSE:WAGE), Spark Therapeutics (NASDAQ:ONCE) and XPO Logistics (NYSEMKT:XPO) on September 18; Determine (NASDAQ:DTRM), Sangamo Therapeutics (NASDAQ:SGMO), Avexis (NASDAQ:AVXS) on September 19; EnSync (NYSEMKT:ESNC) and Alteryx (NYSE:AYX) on September 20; Cotiviti (NYSE:COTV) on September 22.
  • Notable annual meeting: Darden Restaurants (NYSE:DRI) and Nike (NYSE:NKE) on September 21; ConAgra (NYSE:CAG) on September 22.
  • Business update call: Argos Therapeutics (NASDAQ:ARGS) on September 20.
  • Sales update: Raymond James (NYSE:RJF) on September 20.
  • Special shareholder meeting: Intuitive Surgical (NASDAQ:ISRG) and Commerce Bancshares (NASDAQ:CBSH) on September 21.
  • Analyst/investor meeting: Adamas Pharmaceuticals (NASDAQ:ADMS) on September 18; Big Lots (NYSE:BIG), Carbonite (NASDAQ:CARB), CDW (NASDAQ:CDW), Humana (NYSE:HUM), Best Buy (NYSE:BBY) and National Health Investors (NYSE:NHI) on September 19; Pilgrim's Pride (NYSE:PPC), Unisys (UIS) on September 20; Rambus (NASDAQ:RMBS) on September 21.
  • FTC Hart-Scott-Rodino expiration: Walgreens Boots Alliance (NASDAQ:WBA) and Rite Aid (NYSE:RAD) on September 18.
  • FDA watch: Companies that could hear from the government agency include Mylan (NASDAQ:MYL) on Copaxone, Valeant Pharmaceuticals (NYSE:VRX) on latanoprostene bunod CRL and Alnylam Pharmaceuticals (NASDAQ:ALNY)-Sanofi (NYSE:SNY) on patisiran.
  • Hurricane reset: Investors are expected to continue to adjust to the impact from Hurricanes Harvey and Irma after a week that saw significant upward moves for restaurant and insurance stocks. Fundstrat suggests that value stocks like Comcast (NASDAQ:CMCSA) (CMSCSA), FedEx (NYSE:FDX), Procter & Gamble (NYSE:PG), IBM (NYSE:IBM), Merck (NYSE:MRK), Emerson Electric (NYSE:EMR) and Dollar Tree (NASDAQ:DLTR) are the type of names that could see interest with the Fed potentially in a holding pattern. Traders are also keeping an eye on Tropical Storm Jose in the Atlantic with it forecast to threaten the East Coast next week after strengthening.
  • Barron's mentions: Volkswagen (OTCPK:VLKAY), China Mobile (NYSE:CHL), Frost Bank (NYSE:CFR) and MLPs are called out as enticing investment picks. Meanwhile, there is plenty of debate both ways on FedEx, Goldman Sachs (NYSE:GS) and the FANG gang of four - Facebook (NASDAQ:FB), Amazon (NASDAQ:AMZN), Netflix (NASDAQ:NFLX) and Google (GOOG, GOOGL). The publication also suggests watching lumber plays.
  • Sources: EDGAR, Bloomberg, Nasdaq.com.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Original article

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.